On the other hand it seems that in a t(6;9)-AML in absence of FLT3-ITD there is an activation of other signaling pathways such as RAS [2] although DEK-CAN alone is able to induce AML in vivo. This evidence concerns the gene FLT3 and acute myeloid leukemia.